Nonpartisan civic infrastructure
AllCiv·Legis1
·

Cancer Research Institute INC

Public charity990-T FY2023
DBA: % ALFRED MASSIDAS
Other · NEW YORK, NY · EIN 13-1837442

About

See schedule OTHE cancer research institute's mission is to save more lives by fueling the discovery and development of powerful immunotherapies for ALL types of cancer. To accomplish this, CRI funds laboratory, translational, and clinical research. Efforts aimed at learning how to harness the power of the immune system to diagnose, treat, and CURE cancer. CRI also coordinates scientific, medical, and patient education conferences on the subjects of immunology and immunotherapy, and disseminates information in english and spanish about advances in tumor immunology to the media, public, and medical and scientific communities.

In care of Alfred Massidas

Donations are tax-deductible
Category
Other
Employees
32
Volunteers
250

Financial Snapshot

FY ending 2024-06-30
Revenue
$24.0M
Expenses
$32.8M
Assets
$133.7M
Liabilities
$66.9M

Financial history

$42.0M$21.0M$0
1718192021222324
RevenueExpenses
Latest FY2024: $24.0M · Peak FY2019: $42.0M · Avg: $30.3M

Foreign activity (Schedule F)

Total spent abroad$74.0M
Foreign employees0
Foreign offices0
Foreign partnership interestYes
Foreign trust interestNo
RegionActivitySpent
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA,
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM
NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES
MIDDLE EAST AND NORTH AFRICA
CENTRAL AMERICA AND THE CARIBBEAN
NORTH AMERICA

Political & Grant Activity

Campaign Spending
Lobbying
Grants Given
$13.2M
CANCER RESEARCH INSTITUTE INC
Your actions

Address

29 Broadway 4TH Floor
New YORK, NY, 10006-320

Governance

Voting board members33
Independent members33
Conflict-of-interest policyYes
Whistleblower policyYes
Doc-retention policyYes
Audit committeeYes
990 reviewed by boardYes

Compensation practices

Severance paymentsNo
Equity-based compNo
Supplemental retirement planNo
Compensation committeeYes
Board approved compYes
Initial contract exceptionNo

Financial detail (Schedule D)

Board-designated %57.0%
Permanent endowment %29.0%
Endowment held by related orgNo
Public records
ProPublica Nonprofit Explorer
Full 990 PDFs going back to 2001, plus parsed financial extracts. The easiest place to read actual filings.
IRS Tax Exempt Organization Search
IRS-side authoritative source. Confirms current exempt status and pulls the latest determination letter.
These open in a new tab. AllCiv doesn't host filings directly — these are the authoritative public-record sources.